Slides: RAAS inhibition in patients with kidney disease: Balancing the benefits and risks
Slides as educational service to PACE members and meeting participants
This lecture was part of a CME-accredited symposium "RAASi and Hyperkalaemia in Cardiorenal Disease: Opportunities for optimizing outcomes" held during ERA EDTA 2019 in Budapest, Hungary. The presentation was prepared and held by prof. Patrick Rossignol, MD, Professor of Therapeutics at the University of Lorraine, France.
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: